Mechanisms of obesity-associated cardiovascular and renal disease.
about
Resistin, an Adipokine with Non-Generalized Actions on Sympathetic Nerve ActivityType-2 diabetes: Current understanding and future perspectivesControl of metabolic and cardiovascular function by the leptin-brain melanocortin pathwayThe discovery of hypertension: evolving views on the role of the kidneys, and current hot topicsIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesLeptinemia and its association with stroke and coronary heart disease in the Jackson Heart Study.The role of the sympathetic nervous system in obesity-related hypertensionThe brain melanocortin system, sympathetic control, and obesity hypertension.Obesity-Induced Hypertension: Brain Signaling Pathways.Healthy weight - healthy blood pressureObesity hypertension: the regulatory role of leptinCentral obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese.Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implicationsInsulin's microvascular vasodilatory effects are inversely related to peripheral vascular resistance in overweight, but insulin-sensitive subjects.Antiobesity effects of Isaria sinclairii by repeated oral treatment in obese Zucker rats over a 4-month period.Overnutrition and the Cardiorenal Syndrome: Use of a Rodent Model to Examine Mechanisms.Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis[The metabolic syndrome and early kidney disease: another link in the chain?].Cardiovascular and metabolic consequences of obesityObesity-induced hypertension: interaction of neurohumoral and renal mechanismsImpact of obesity on childhood kidneyAssociation of Demographic and Socioeconomic Factors With Risk Factors for Chronic Kidney Disease.Metabolic syndrome leading to chronic kidney disease: An emerging threatHigh body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney diseaseLeptin, fetal nutrition, and long-term outcomes for adult hypertension.Therapy insight: weight-loss surgery and major cardiovascular risk factors.Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults.Obesity and diabetic kidney disease.Emerging global epidemic of obesity: the renal perspective.Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma riskIntermittent exercise improves the vasoreactivity of the thoracic aorta in rats.Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach.Obesity and insulin resistance as risk factors for chronic kidney disease.Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarctionEvaluation of Autonomic Dysfunction in Obese and Non-Obese Hypertensive SubjectsAnti-obesity activity of chloroform-methanol extract of Premna integrifolia in mice fed with cafeteria diet.Body size and renal cell cancer incidence in a large US cohort studyFatty Acid Composition of Adipose Tissues in Obese Mice and SD Rats Fed with Isaria sinclairii Powder.Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.Blood pressure control and components of the metabolic syndrome: the GOOD survey.
P2860
Q26776170-17B1F9A6-786F-45B8-94B1-70753D1687F9Q26801324-0E946C89-CD76-47A1-9854-888ADE4C0AD7Q26824250-4145FACA-2E6E-469D-85CC-765D978A5A17Q26830489-4C26EA39-847F-45D7-AFB8-2B9380DADD8DQ28388335-B3EBDA1E-083F-4A01-A17C-2ECE0B748408Q33584896-F92FA2FD-968F-4266-BCAF-142C5B8EAEFBQ33622500-7016BB53-5B05-4937-A384-509B947B54E5Q33716111-65886B5A-AC62-4378-B437-FC0E803874B9Q33739338-F6358534-590A-4EF4-8DCC-D27166689EF1Q33916683-78F02903-576B-40E1-8308-42BF6F831FFFQ34496907-2C3CBFC7-3B29-4FAF-AC8F-F51CB182EA83Q34515571-EA814F86-816B-4FC6-86C0-31F3F6979F03Q34556186-1B75FE0C-C68F-45E5-9063-7FB9F91EAC4DQ34628166-1B51E6A2-BA35-40A7-AA4D-F6B6A80C29F0Q34656110-BD5A2CF9-A493-47ED-8DB8-F4E04582C3E9Q35005382-3E05DF43-4322-47E9-A955-DB08965B2185Q35006811-D78AB8E9-D73C-4B07-B924-A9A9148640E3Q35024273-3719EF3A-E4CC-4BF5-91D8-2B43D0BEADF7Q35067428-81460D81-4ABE-4B24-92DD-BBD4ED24356CQ35186358-A6722DB4-D2E7-45DD-9983-D38256C2083AQ35768447-3EEE5B4F-BF4F-4653-8858-D9CBD07D644DQ35793073-D74FDD43-41CE-4981-A0F4-0D6FE4EEC518Q35856023-E6571DD5-8F78-4C04-B019-E484268FC7FCQ36150906-71C97C76-FA32-4E1E-A84D-31D7CD8AAE0FQ36203519-095F0ED6-FDDA-4D81-8D23-18CB233AB26BQ36301144-6EB99CDC-32D0-4908-92B5-FB952185FA27Q36364214-9AFA25A0-E360-4E46-8D27-283AECF4F038Q36515043-3F8DF28D-8682-4E7C-A119-7733A157E8C0Q36554341-09E88113-6C14-4797-9F74-3EE6D222A0A2Q36697770-37F430AD-3747-47C3-8080-43C207A00A37Q36742053-1F08D0DF-F8FC-44CF-9C7A-32BEB31838BCQ36752075-30F153D3-C6FD-4177-9AFF-69D177CA82E0Q36902752-9A0E1896-687A-4FB8-A7BD-90DDA00F5748Q36903856-7D66BB7F-AA5A-425F-A9B5-3A756E8F0184Q37132756-C0B211E5-731C-4EE3-86AD-0CB19820C2E0Q37186591-99C4C971-BE1B-4460-B4BC-36C1A4382D76Q37306225-38821B43-0E46-412E-BE55-6AB879EEE325Q37326594-749CAC78-E936-4FB0-9416-E290EBB377FDQ37337571-22BAE7C8-5354-43A4-A69E-A51E005291CBQ37375160-C26E762E-1543-4B62-9F30-C8ECDF22DC94
P2860
Mechanisms of obesity-associated cardiovascular and renal disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mechanisms of obesity-associated cardiovascular and renal disease.
@ast
Mechanisms of obesity-associated cardiovascular and renal disease.
@en
Mechanisms of obesity-associated cardiovascular and renal disease.
@nl
type
label
Mechanisms of obesity-associated cardiovascular and renal disease.
@ast
Mechanisms of obesity-associated cardiovascular and renal disease.
@en
Mechanisms of obesity-associated cardiovascular and renal disease.
@nl
prefLabel
Mechanisms of obesity-associated cardiovascular and renal disease.
@ast
Mechanisms of obesity-associated cardiovascular and renal disease.
@en
Mechanisms of obesity-associated cardiovascular and renal disease.
@nl
P2093
P1476
Mechanisms of obesity-associated cardiovascular and renal disease.
@en
P2093
Daniel W Jones
Errol D Crook
John E Hall
Marion R Wofford
Patricia M Dubbert
P304
P356
10.1097/00000441-200209000-00003
P407
P577
2002-09-01T00:00:00Z